Prediction of Successful Liberation from Continuous Renal Replacement Therapy Using a Novel Biomarker in Patients with Acute Kidney Injury after Cardiac Surgery—An Observational Trial
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252010873 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Johanna Tichy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, Division of Cardiac Thoracic Vascular Anesthesia and Intensive Care Medicine…. Hauptthemen laut MEDLINE: Acute Kidney Injury, Biomarkers, Cardiac Surgical Procedures, Continuous Renal Replacement Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sphingotec GmBH, Henningsdorf, Germany.
Abstract (Originalsprache)
An acute kidney injury (AKI) is the most common complication following cardiac surgery, and can lead to the initiation of continuous renal replacement therapy (CRRT). However, there is still insufficient evidence for when patients should be liberated from CRRT. Proenkephalin A 119–159 (PENK) is a novel biomarker that reflects kidney function independently of other factors. This study investigated whether PENK could guide successful liberation from CRRT. Therefore, we performed a prospective, observational, single-center study at the Medical University of Vienna between July 2022 and May 2023, which included adult patients who underwent cardiac surgery for a cardiopulmonary bypass; patients on preoperative RRT were excluded. The PENK levels were measured at the time of AKI diagnosis and at the initiation of and liberation from CRRT, and were subsequently compared to determine whether the patients were successfully liberated from CRRT. We screened 61 patients with postoperative AKI; 20 patients experienced a progression of AKI requiring CRRT. The patients who were successfully liberated from CRRT had mean PENK levels of 113 ± 95.4 pmol/L, while the patients who were unsuccessfully liberated from CRRT had mean PENK levels of 290 ± 175 pmol/L (p = 0.018). For the prediction of the successful liberation from CRRT, we found an area under the curve of 0.798 (95% CI, 0.599–0.997) with an optimal threshold value of 126.7 pmol/L for PENK (Youden Index = 0.53, 95% CI, 0.10–0.76) at the time of CRRT liberation (sensitivity = 0.64, specificity = 0.89). In conclusion, PENK is a novel biomarker that has the potential to predict the successful liberation from CRRT for patients with AKI after cardiac surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, Division of Cardiac Thoracic Vascular Anesthesia and Intensive Care Medicine, Medical University of Vienna, 1090 Vienna, Austria.
- Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, 1090 Vienna, Austria.
ORCID-Profile: Andrea Hausmann, Martin H Bernardi
Förderung
- Sphingotec GmBH, Henningsdorf, Germany
Zitieren
APA
Tichy, J., Hausmann, A., Lanzerstorfer, J., Ryz, S., Wagner, L., Lassnigg, A., & Bernardi, M. H. (2024). Prediction of Successful Liberation from Continuous Renal Replacement Therapy Using a Novel Biomarker in Patients with Acute Kidney Injury after Cardiac Surgery—An Observational Trial. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252010873
Vancouver
Tichy J, Hausmann A, Lanzerstorfer J, Ryz S, Wagner L, Lassnigg A, et al. Prediction of Successful Liberation from Continuous Renal Replacement Therapy Using a Novel Biomarker in Patients with Acute Kidney Injury after Cardiac Surgery—An Observational Trial. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252010873
BibTeX
@article{Tichy2024,
author = {Tichy, Johanna and Hausmann, Andrea and Lanzerstorfer, Johannes and Ryz, Sylvia and Wagner, Ludwig and Lassnigg, Andrea and Bernardi, Martin H},
title = {Prediction of Successful Liberation from Continuous Renal Replacement Therapy Using a Novel Biomarker in Patients with Acute Kidney Injury after Cardiac Surgery—An Observational Trial},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252010873}
}
EUVIMED